{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T16:09:10Z","timestamp":1791648550003,"version":"4.3.4"},"reference-count":257,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neuroscience"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/j.neuroscience.2013.04.034","type":"journal-article","created":{"date-parts":[[2013,4,24]],"date-time":"2013-04-24T05:16:30Z","timestamp":1366780590000},"page":"637-654","source":"Crossref","is-referenced-by-count":197,"special_numbering":"C","title":["Cannabinoid and opioid interactions: Implications for opiate dependence and withdrawal"],"prefix":"10.1016","volume":"248","author":[{"given":"J.L.","family":"Scavone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.C.","family":"Sterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.J.","family":"Van Bockstaele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuroscience.2013.04.034_b0005","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1523\/JNEUROSCI.07-09-02844.1987","article-title":"Single-unit response of noradrenergic neurons in the locus coeruleus of freely moving cats. II. Adaptation to chronically presented stressful stimuli","volume":"7","author":"Abercrombie","year":"1987","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0010","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/0006-8993(94)90186-4","article-title":"Opiate withdrawal increases glutamate and aspartate efflux in the locus coeruleus: an in vivo microdialysis study","volume":"636","author":"Aghajanian","year":"1994","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0015","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1176\/appi.ajp.162.8.1507","article-title":"Postdischarge cannabis use and its relationship to cocaine, alcohol, and heroin use: a prospective study","volume":"162","author":"Aharonovich","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0020","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1523\/JNEUROSCI.11-12-03830.1991","article-title":"Opiate withdrawal-induced hyperactivity of locus coeruleus neurons is substantially mediated by augmented excitatory amino acid input","volume":"11","author":"Akaoka","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0025","doi-asserted-by":"crossref","first-page":"5769","DOI":"10.1523\/JNEUROSCI.22-13-05769.2002","article-title":"Mu-opioid receptors: ligand-dependent activation of potassium conductance, desensitization, and internalization","volume":"22","author":"Alvarez","year":"2002","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0030","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1523\/JNEUROSCI.0303-06.2006","article-title":"Separation of mu-opioid receptor desensitization and internalization: endogenous receptors in primary neuronal cultures","volume":"26","author":"Arttamangkul","year":"2006","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0035","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1523\/JNEUROSCI.01-08-00887.1981","article-title":"Nonrepinephrine-containing locus coeruleus neurons in behaving rats exhibit pronounced responses to non-noxious environmental stimuli","volume":"1","author":"Aston-Jones","year":"1981","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0040","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.biopsych.2008.03.016","article-title":"Brain norepinephrine rediscovered in addiction research","volume":"63","author":"Aston-Jones","year":"2008","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0045","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1126\/science.3775363","article-title":"The brain nucleus locus coeruleus: restricted afferent control of a broad efferent network","volume":"234","author":"Aston-Jones","year":"1986","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0050","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0079-6123(08)63799-1","article-title":"Afferent regulation of locus coeruleus neurons: anatomy, physiology and pharmacology","volume":"88","author":"Aston-Jones","year":"1991","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ar.a.20184","article-title":"Vesicular glutamate transporter-1 colocalizes with endogenous opioid peptides in axon terminals of the rat locus coeruleus","volume":"284","author":"Barr","year":"2005","journal-title":"Anat Rec A Discov Mol Cell Evol Biol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0060","doi-asserted-by":"crossref","first-page":"735","DOI":"10.15288\/jsad.2009.70.735","article-title":"Craving and self-efficacy in the first five weeks of methadone maintenance therapy: a daily process study","volume":"70","author":"Barta","year":"2009","journal-title":"J Stud Alcohol Drugs"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0065","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2174\/157015907780866910","article-title":"Neuropharmacology of the endocannabinoid signaling system-molecular mechanisms, biological actions and synaptic plasticity","volume":"5","author":"Basavarajappa","year":"2007","journal-title":"Curr Neuropharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0070","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0165-0173(03)00143-7","article-title":"The locus coeruleus-noradrenergic system: modulation of behavioral state and state-dependent cognitive processes","volume":"42","author":"Berridge","year":"2003","journal-title":"Brain Res Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0075","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/01.ajp.0000210915.80417.cf","article-title":"Estimated costs of prescription opioid analgesic abuse in the United States in 2001: a societal perspective","volume":"22","author":"Birnbaum","year":"2006","journal-title":"Clin J Pain"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0080","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bcp.2010.02.013","article-title":"Functionally selective cannabinoid receptor signalling: therapeutic implications and opportunities","volume":"80","author":"Bosier","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0085","doi-asserted-by":"crossref","first-page":"9989","DOI":"10.1523\/JNEUROSCI.18-23-09989.1998","article-title":"Regulation of tyrosine hydroxylase promoter activity by chronic morphine in TH9.0-LacZ transgenic mice","volume":"18","author":"Boundy","year":"1998","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0090","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1046\/j.1360-0443.1998.931738.x","article-title":"A meta-analysis of predictors of continued drug use during and after treatment for opiate addiction","volume":"93","author":"Brewer","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0095","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2105\/AJPH.89.10.1549","article-title":"The risks for late adolescence of early adolescent marijuana use","volume":"89","author":"Brook","year":"1999","journal-title":"Am J Public Health"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0100","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1017\/S0033291701004809","article-title":"Early adolescent marijuana use: risks for the transition to young adulthood","volume":"32","author":"Brook","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0105","doi-asserted-by":"crossref","first-page":"28S","DOI":"10.1002\/j.1552-4604.2002.tb06000.x","article-title":"Development and consequences of cannabis dependence","volume":"42","author":"Budney","year":"2002","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0110","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1360-0443.1998.9344935.x","article-title":"Marijuana use and treatment outcome among opioid-dependent patients","volume":"93","author":"Budney","year":"1998","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s002130100875","article-title":"Behavioural sensitization after repeated exposure to delta 9-tetrahydrocannabinol and cross-sensitization with morphine","volume":"158","author":"Cadoni","year":"2001","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0120","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0014-2999(03)01285-8","article-title":"Neuroendocrine pharmacology of stress","volume":"463","author":"Carrasco","year":"2003","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0125","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.neulet.2011.06.008","article-title":"Direct intra-accumbal infusion of a beta-adrenergic receptor antagonist abolishes WIN 55,212-2-induced aversion","volume":"500","author":"Carvalho","year":"2011","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0130","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/j.1460-9568.2009.07054.x","article-title":"Cannabinoid modulation of limbic forebrain noradrenergic circuitry","volume":"31","author":"Carvalho","year":"2010","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0135","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00213-010-1923-7","article-title":"Contribution of limbic norepinephrine to cannabinoid-induced aversion","volume":"211","author":"Carvalho","year":"2010","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0140","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1126\/science.7403874","article-title":"Alterations in brain norepinephrine metabolism induced by environmental stimuli previously paired with inescapable shock","volume":"209","author":"Cassens","year":"1980","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0145","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1615\/CritRevNeurobiol.v13.i3.20","article-title":"Behavioral effects of cannabinoid agents in animals","volume":"13","author":"Chaperon","year":"1999","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0150","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/(SICI)1096-9861(19960805)371:4<522::AID-CNE3>3.0.CO;2-6","article-title":"Immunolabeling of Mu opioid receptors in the rat nucleus of the solitary tract: extrasynaptic plasmalemmal localization and association with Leu5-enkephalin","volume":"371","author":"Cheng","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0155","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1749-6632.1992.tb25954.x","article-title":"Opioid and cannabinoid receptor inhibition of adenylyl cyclase in brain","volume":"654","author":"Childers","year":"1992","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0160","first-page":"158","article-title":"Mechanisms of tolerance to opiates in locus coeruleus neurons","volume":"78","author":"Christie","year":"1987","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0165","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1081\/ADA-100104511","article-title":"Concurrent substance use and outcome in combined behavioral and naltrexone therapy for opiate dependence","volume":"27","author":"Church","year":"2001","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0170","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.lfs.2003.09.038","article-title":"Synergistic interactions between cannabinoid and opioid analgesics","volume":"74","author":"Cichewicz","year":"2004","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0175","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1124\/jpet.102.045575","article-title":"Antinociceptive synergy between delta(9)-tetrahydrocannabinol and opioids after oral administration","volume":"304","author":"Cichewicz","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0180","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1124\/jpet.102.046870","article-title":"Modulation of oral morphine antinociceptive tolerance and naloxone-precipitated withdrawal signs by oral delta 9-tetrahydrocannabinol","volume":"305","author":"Cichewicz","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0185","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0022-3565(24)38212-6","article-title":"Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification","volume":"289","author":"Cichewicz","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0190","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1080\/15360280902727973","article-title":"Medical marijuana: the conflict between scientific evidence and political ideology. Part one of two","volume":"23","author":"Cohen","year":"2009","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0195","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1080\/15360280902900620","article-title":"Medical marijuana: the conflict between scientific evidence and political ideology. Part two of two","volume":"23","author":"Cohen","year":"2009","journal-title":"J Pain Palliat Care Pharmacother"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0200","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1111\/j.1748-720X.2010.00519.x","article-title":"Medical marijuana 2010: it\u2019s time to fix the regulatory vacuum","volume":"38","author":"Cohen","year":"2010","journal-title":"J Law Med Ethics"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0205","doi-asserted-by":"crossref","first-page":"PL 39","DOI":"10.1016\/S0024-3205(97)00405-0","article-title":"Delta-9-tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat","volume":"61","author":"Corchero","year":"1997","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0210","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S0014-2999(97)00144-1","article-title":"Delta 9-tetrahydrocannabinol increases proopiomelanocortin gene expression in the arcuate nucleus of the rat hypothalamus","volume":"323","author":"Corchero","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S0169-328X(99)00053-4","article-title":"Time-dependent differences of repeated administration with delta9-tetrahydrocannabinol in proenkephalin and cannabinoid receptor gene expression and G-protein activation by mu-opioid and CB1-cannabinoid receptors in the caudate-putamen","volume":"67","author":"Corchero","year":"1999","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0220","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1615\/CritRevNeurobiol.v16.i12.170","article-title":"Cannabinoid\/opioid crosstalk in the central nervous system","volume":"16","author":"Corchero","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0225","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1177\/0269881104040237","article-title":"Repeated administration with Delta9-tetrahydrocannabinol regulates mu-opioid receptor density in the rat brain","volume":"18","author":"Corchero","year":"2004","journal-title":"J Psychopharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0230","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1046\/j.1471-4159.1998.71051865.x","article-title":"Cell type-specific regulation of CREB gene expression: mutational analysis of CREB promoter activity","volume":"71","author":"Coven","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0235","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ejphar.2007.04.010","article-title":"Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat","volume":"567","author":"Cox","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0240","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0014-2999(79)90372-8","article-title":"Clonidine reversal of increased norepinephrine metabolite levels during morphine withdrawal","volume":"57","author":"Crawley","year":"1979","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0245","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1124\/mol.105.013185","article-title":"Morphine-induced mu-opioid receptor desensitization","volume":"68","author":"Dang","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0250","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1007\/s00213-003-1422-1","article-title":"Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats","volume":"168","author":"De Vries","year":"2003","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0255","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0376-8716(01)00130-2","article-title":"The relationship between cannabis use and other substance use in the general population","volume":"64","author":"Degenhardt","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0260","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0014-2999(02)02483-4","article-title":"Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404","volume":"454","author":"Del Arco","year":"2002","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0265","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.lfs.2005.05.055","article-title":"Cannabinoid signalling","volume":"78","author":"Demuth","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0270","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/BF02245592","article-title":"Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants","volume":"121","author":"Detke","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0275","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0280","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S0031-6997(25)06958-3","article-title":"International Union of Pharmacology. XII. Classification of opioid receptors","volume":"48","author":"Dhawan","year":"1996","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0285","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","article-title":"Formation and inactivation of endogenous cannabinoid anandamide in central neurons","volume":"372","author":"Di Marzo","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0290","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1007\/3-540-26573-2_5","article-title":"The biosynthesis, fate and pharmacological properties of endocannabinoids","author":"Di Marzo","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0295","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1096-9861(19960408)367:3<375::AID-CNE5>3.0.CO;2-2","article-title":"Immunohistochemical localization of mu-opioid receptors in the central nervous system of the rat","volume":"367","author":"Ding","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0300","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1196\/annals.1296.003","article-title":"Brain circuits involved in corticotropin-releasing factor-norepinephrine interactions during stress","volume":"1018","author":"Dunn","year":"2004","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1320","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.euroneuro.2008.06.009","article-title":"Dynamic changes of the endogenous cannabinoid and opioid mesocorticolimbic systems during adolescence: THC effects","volume":"18","author":"Ellgren","year":"2008","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1325","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1038\/sj.npp.1301127","article-title":"Adolescent cannabis exposure alters opiate intake and opioid limbic neuronal populations in adult rats","volume":"32","author":"Ellgren","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0315","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1037\/0022-006X.45.4.709","article-title":"Marijuana use by heroin abusers as a factor in program retention","volume":"45","author":"Ellner","year":"1977","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0320","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1046\/j.1360-0443.2003.00310.x","article-title":"Does cannabis use predict poor outcome for heroin-dependent patients on maintenance treatment? Past findings and more evidence against","volume":"98","author":"Epstein","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0325","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1360-0443.1994.tb03745.x","article-title":"Opiate withdrawal","volume":"89","author":"Farrell","year":"1994","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0330","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1615\/CritRevNeurobiol.v16.i12.160","article-title":"Cannabinoids and reward: interactions with the opioid system","volume":"16","author":"Fattore","year":"2004","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0335","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.pbb.2005.01.031","article-title":"Endocannabinoid system and opioid addiction: behavioural aspects","volume":"81","author":"Fattore","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0340","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.neuropharm.2005.01.022","article-title":"Cannabinoid CB(1) antagonist SR 141716A attenuates reinstatement of heroin self-administration in heroin-abstinent rats","volume":"48","author":"Fattore","year":"2005","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0345","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.brainresrev.2006.05.003","article-title":"An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives","volume":"53","author":"Fattore","year":"2007","journal-title":"Brain Res Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0350","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1111\/j.1460-9568.2007.05470.x","article-title":"Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2","volume":"25","author":"Fattore","year":"2007","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0355","doi-asserted-by":"crossref","first-page":"S97","DOI":"10.1016\/j.mce.2008.02.006","article-title":"Neurobiological mechanisms of cannabinoid addiction","volume":"286","author":"Fattore","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0360","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF02246086","article-title":"Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed \u201cetho-score\u201d","volume":"122","author":"Fernandez Espejo","year":"1995","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0365","doi-asserted-by":"crossref","first-page":"e72","DOI":"10.1111\/j.1755-5949.2010.00144.x","article-title":"Cannabinoid\u2013dopamine interaction in the pathophysiology and treatment of CNS disorders","volume":"16","author":"Fernandez-Ruiz","year":"2010","journal-title":"CNS Neurosci Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0370","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/S0006-3223(99)00157-2","article-title":"Role of norepinephrine in mediating stress hormone regulation of long-term memory storage: a critical involvement of the amygdala","volume":"46","author":"Ferry","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0375","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-003-0807-0","article-title":"Perturbations in brain monoamine systems during stress","volume":"315","author":"Flugge","year":"2004","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0380","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(25)30692-0","article-title":"Correlation between the in vivo and an in vitro expression of opiate withdrawal precipitated by naloxone: their antagonism by l-(\u2212)-delta9-tetrahydrocannabinol","volume":"199","author":"Frederickson","year":"1976","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0385","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","article-title":"Role of endogenous cannabinoids in synaptic signaling","volume":"83","author":"Freund","year":"2003","journal-title":"Physiol Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0390","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1054\/plef.2001.0360","article-title":"Endocannabinoids in the central nervous system \u2013 an overview","volume":"66","author":"Fride","year":"2002","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0395","doi-asserted-by":"crossref","first-page":"PL 113","DOI":"10.1016\/0024-3205(94)90010-8","article-title":"Role of beta-adrenoceptors in the expression of morphine withdrawal signs","volume":"54","author":"Funada","year":"1994","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0400","doi-asserted-by":"crossref","first-page":"432","DOI":"10.2174\/187152709789824642","article-title":"Cannabinoids and Parkinson\u2019s disease","volume":"8","author":"Garcia-Arencibia","year":"2009","journal-title":"CNS Neurol Disord Drug Targets"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0405","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/S0022-3565(25)31261-9","article-title":"Development and maintenance of morphine tolerance and dependence in the rat by scheduled access to morphine drinking solutions","volume":"205","author":"Gellert","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0410","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0740-5472(01)00178-7","article-title":"Lofexidine versus clonidine in rapid opiate detoxification","volume":"21","author":"Gerra","year":"2001","journal-title":"J Subst Abuse Treat"},{"issue":"Suppl. 2","key":"10.1016\/j.neuroscience.2013.04.034_b0415","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1111\/j.1526-4637.2009.00668.x","article-title":"The burden of the nonmedical use of prescription opioid analgesics","volume":"10","author":"Gilson","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0420","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.lfs.2006.02.016","article-title":"Post-opioid receptor adaptations to chronic morphine; altered functionality and associations of signaling molecules","volume":"79","author":"Gintzler","year":"2006","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0425","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0022-3565(24)29345-9","article-title":"Mechanisms of endocannabinoid inactivation: biochemistry and pharmacology","volume":"298","author":"Giuffrida","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0430","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0193-953X(18)30190-4","article-title":"Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine","volume":"16","author":"Gold","year":"1993","journal-title":"Psychiatr Clin North Am"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0435","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1176\/ajp.136.1.100","article-title":"Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal","volume":"136","author":"Gold","year":"1979","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0440","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1016\/j.neubiorev.2008.03.004","article-title":"Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders","volume":"32","author":"Gorzalka","year":"2008","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0445","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/0376-8716(88)90078-6","article-title":"Clonidine and the treatment of the opiate withdrawal syndrome","volume":"21","author":"Gossop","year":"1988","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0450","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1300\/J069v12n04_04","article-title":"Diminished illicit drug use as a consequence of long-term methadone maintenance","volume":"12","author":"Gottheil","year":"1993","journal-title":"J Addict Dis"},{"issue":"4","key":"10.1016\/j.neuroscience.2013.04.034_b0455","first-page":"CD002024","article-title":"Alpha2 adrenergic agonists for the management of opioid withdrawal","volume":"18","author":"Gowing","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1290","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1111\/j.1755-5949.2010.00195.x","article-title":"The multiplicity of action of cannabinoids: implications for reating neurodegeneration","volume":"17","author":"Gowran","year":"2011","journal-title":"CNS Neurosci Ther."},{"key":"10.1016\/j.neuroscience.2013.04.034_b0465","doi-asserted-by":"crossref","first-page":"ra 54","DOI":"10.1126\/scisignal.2000807","article-title":"Increased abundance of opioid receptor heteromers after chronic morphine administration","volume":"3","author":"Gupta","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0470","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1523\/JNEUROSCI.11-02-00563.1991","article-title":"Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study","volume":"11","author":"Herkenham","year":"1991","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0475","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/13556210500123514","article-title":"Low efficacy of non-opioid drugs in opioid withdrawal symptoms","volume":"10","author":"Hermann","year":"2005","journal-title":"Addict Biol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0480","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.ejphar.2004.06.069","article-title":"Enhancement of anxiety-like responsiveness to the cannabinoid CB(1) receptor agonist HU-210 following chronic stress","volume":"499","author":"Hill","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0485","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.pnpbp.2009.11.001","article-title":"Involvement of the endocannabinoid system in the neurobehavioural effects of stress and glucocorticoids","volume":"34","author":"Hill","year":"2010","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0490","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/hipo.20386","article-title":"Prolonged glucocorticoid treatment decreases cannabinoid CB1 receptor density in the hippocampus","volume":"18","author":"Hill","year":"2008","journal-title":"Hippocampus"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0495","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1254\/jphs.08244FP","article-title":"Mu-opioid receptor forms a functional heterodimer with cannabinoid CB1 receptor: electrophysiological and FRET assay analysis","volume":"108","author":"Hojo","year":"2008","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0500","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0031-6997(25)06862-0","article-title":"Health aspects of cannabis","volume":"38","author":"Hollister","year":"1986","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0505","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0006-8993(00)01981-8","article-title":"Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, delta(9)-THC and anandamide","volume":"857","author":"Houser","year":"2000","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0510","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/0166-2236(90)90124-S","article-title":"The cannabinoid receptor: biochemical, anatomical and behavioral characterization","volume":"13","author":"Howlett","year":"1990","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0515","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","article-title":"International Union of Pharmacology. XXVII. Classification of cannabinoid receptors","volume":"54","author":"Howlett","year":"2002","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0520","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1749-6632.1981.tb12807.x","article-title":"Opiate withdrawal syndrome: acute and protracted aspects","volume":"362","author":"Jasinski","year":"1981","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0525","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.brainresbull.2008.10.014","article-title":"Localization and phenotypic characterization of brainstem neurons activated by rimonabant and WIN55,212-2","volume":"78","author":"Jelsing","year":"2009","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0530","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S0006-8993(02)03367-X","article-title":"Opioid circuits originating from the nucleus paragigantocellularis and their potential role in opiate withdrawal","volume":"955","author":"Johnson","year":"2002","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0535","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000093044","article-title":"The role of opioid receptor phosphorylation and trafficking in adaptations to persistent opioid treatment","volume":"14","author":"Johnson","year":"2005","journal-title":"Neurosignals"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0540","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1124\/mol.104.006882","article-title":"Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk?","volume":"67","author":"Kearn","year":"2005","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0545","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1176\/ajp.155.8.1016","article-title":"Cannabis use, abuse, and dependence in a population-based sample of female twins","volume":"155","author":"Kendler","year":"1998","journal-title":"Am J Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0550","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/0166-2236(92)90171-4","article-title":"Neural substrates of opiate withdrawal","volume":"15","author":"Koob","year":"1992","journal-title":"Trends Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0555","doi-asserted-by":"crossref","first-page":"6516","DOI":"10.1523\/JNEUROSCI.0390-08.2008","article-title":"Presynaptic inhibition of diverse afferents to the locus ceruleus by kappa-opiate receptors: a novel mechanism for regulating the central norepinephrine system","volume":"28","author":"Kreibich","year":"2008","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0560","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/S0959-4388(02)00328-8","article-title":"Retrograde signaling by endocannabinoids","volume":"12","author":"Kreitzer","year":"2002","journal-title":"Curr Opin Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0565","doi-asserted-by":"crossref","first-page":"7890","DOI":"10.1523\/JNEUROSCI.17-20-07890.1997","article-title":"CREB (cAMP response element-binding protein) in the locus coeruleus: biochemical, physiological, and behavioral evidence for a role in opiate dependence","volume":"17","author":"Lane-Ladd","year":"1997","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0570","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/S0022-3565(24)29469-6","article-title":"Opioid and cannabinoid modulation of precipitated withdrawal in delta(9)-tetrahydrocannabinol and morphine-dependent mice","volume":"298","author":"Lichtman","year":"2001","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0575","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00228-010-0793-6","article-title":"The pharmacological treatment of opioid addiction \u2013 a clinical perspective","volume":"66","author":"Lobmaier","year":"2010","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0580","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2174\/138945010790980312","article-title":"Functional interactions between endogenous cannabinoid and opioid systems: focus on alcohol, genetics and drug-addicted behaviors","volume":"11","author":"Lopez-Moreno","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0585","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.pbb.2005.02.017","article-title":"Cognitive consequences of cannabis use: comparison with abuse of stimulants and heroin with regard to attention, memory and executive functions","volume":"81","author":"Lundqvist","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0590","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1365-2354.2008.00917.x","article-title":"Therapeutic use of Cannabis sativa on chemotherapy-induced nausea and vomiting among cancer patients: systematic review and meta-analysis","volume":"17","author":"Machado Rocha","year":"2008","journal-title":"Eur J Cancer Care (Engl)"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0595","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1016\/j.lfs.2005.05.011","article-title":"Cannabinoid receptor homo- and heterodimerization","volume":"77","author":"Mackie","year":"2005","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0600","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/3-540-26573-2_10","article-title":"Distribution of cannabinoid receptors in the central and peripheral nervous system","author":"Mackie","year":"2005","journal-title":"Handb Exp Pharmacol"},{"issue":"Suppl. 1","key":"10.1016\/j.neuroscience.2013.04.034_b0605","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1365-2826.2008.01671.x","article-title":"Cannabinoid receptors: where they are and what they do","volume":"20","author":"Mackie","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0610","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0149-7634(95)00061-5","article-title":"Participation of noradrenergic pathways in the expression of opiate withdrawal: biochemical and pharmacological evidence","volume":"21","author":"Maldonado","year":"1997","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0615","first-page":"1","article-title":"The neurobiology of addiction","author":"Maldonado","year":"2003","journal-title":"J Neural Transm Suppl"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0620","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/0006-8993(93)91364-X","article-title":"Destruction of the locus coeruleus decreases physical signs of opiate withdrawal","volume":"605","author":"Maldonado","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0625","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.euroneuro.2003.08.001","article-title":"Participation of the opioid system in cannabinoid-induced antinociception and emotional-like responses","volume":"13","author":"Maldonado","year":"2003","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0630","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0022-3565(25)11090-2","article-title":"Role of different brain structures in the expression of the physical morphine withdrawal syndrome","volume":"261","author":"Maldonado","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1295","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/0028-3908(92)90051-P","article-title":"Precipitation of morphine withdrawal syndrome in rats by administration of mu-, delta- and kappa-selective opioid antagonists","volume":"31","author":"Maldonado","year":"1992","journal-title":"Neuropharmacology."},{"key":"10.1016\/j.neuroscience.2013.04.034_b0635","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF00169392","article-title":"Protein kinases in the locus coeruleus and periaqueductal gray matter are involved in the expression of opiate withdrawal","volume":"352","author":"Maldonado","year":"1995","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0640","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0891-0618(95)00055-C","article-title":"Immunohistochemical localization of the cloned mu opioid receptor in the rat CNS","volume":"8","author":"Mansour","year":"1995","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0645","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S0169-328X(97)00371-9","article-title":"Chronic administration of cannabinoids regulates proenkephalin mRNA levels in selected regions of the rat brain","volume":"55","author":"Manzanares","year":"1998","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0650","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-6147(99)01339-5","article-title":"Pharmacological and biochemical interactions between opioids and cannabinoids","volume":"20","author":"Manzanares","year":"1999","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0655","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1080\/02791072.2010.10399789","article-title":"Differential substance abuse patterns distribute according to gender in heroin addicts","volume":"42","author":"Maremmani","year":"2010","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0660","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0376-8716(00)00162-9","article-title":"The economic costs of heroin addiction in the United States","volume":"61","author":"Mark","year":"2001","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0665","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S0024-3205(99)00281-7","article-title":"Discovery and characterization of endogenous cannabinoids","volume":"65","author":"Martin","year":"1999","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0670","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1038\/sj.bjp.0703990","article-title":"Reduction of opioid dependence by the CB(1) antagonist SR141716A in mice: evaluation of the interest in pharmacotherapy of opioid addiction","volume":"132","author":"Mas-Nieto","year":"2001","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0675","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S0165-5728(01)00323-X","article-title":"Comparative characterization in the rat of the interaction between cannabinoids and opiates for their immunosuppressive and analgesic effects","volume":"117","author":"Massi","year":"2001","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0680","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejphar.2009.09.055","article-title":"Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis","volume":"624","author":"McLaughlin","year":"2009","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0685","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.drugalcdep.2009.12.008","article-title":"A comparison of methadone, buprenorphine and alpha(2) adrenergic agonists for opioid detoxification: a mixed treatment comparison meta-analysis","volume":"108","author":"Meader","year":"2010","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0690","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","article-title":"Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors","volume":"50","author":"Mechoulam","year":"1995","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0014-2999(98)00649-9","article-title":"Endocannabinoids","volume":"359","author":"Mechoulam","year":"1998","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0700","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2004.02.073","article-title":"Cannabinoids enhance N-methyl-d-aspartate-induced excitation of locus coeruleus neurons by CB1 receptors in rat brain slices","volume":"363","author":"Mendiguren","year":"2004","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1300","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices","volume":"534","author":"Mendiguren","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0710","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ejphar.2006.01.002","article-title":"Systemic effect of cannabinoids on the spontaneous firing rate of locus coeruleus neurons in rats","volume":"534","author":"Mendiguren","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0715","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.neuropharm.2006.09.004","article-title":"CB(1) cannabinoid receptors inhibit the glutamatergic component of KCl-evoked excitation of locus coeruleus neurons in rat brain slices","volume":"52","author":"Mendiguren","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0720","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1460-9568.1997.tb01361.x","article-title":"Electron microscopic distribution of mu opioid receptors on noradrenergic neurons of the locus coeruleus","volume":"9","author":"Moyse","year":"1997","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0730","doi-asserted-by":"crossref","first-page":"2385","DOI":"10.1111\/j.1460-9568.2006.04759.x","article-title":"Cannabinoids modulate spontaneous neuronal activity and evoked inhibition of locus coeruleus noradrenergic neurons","volume":"23","author":"Muntoni","year":"2006","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1305","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00414-009-0361-8","article-title":"Comparison of urine results concerning co-consumption of illicit heroin and other drugs in heroin and methadone maintenance programs","volume":"124","author":"Musshoff","year":"2010","journal-title":"Int J Legal Med."},{"key":"10.1016\/j.neuroscience.2013.04.034_b0740","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.pnpbp.2007.03.013","article-title":"Chronic cannabis use does not affect the normalization of hypothalamic\u2013pituitary\u2013adrenal (HPA) axis induced by methadone in heroin addicts","volume":"31","author":"Nava","year":"2007","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0745","doi-asserted-by":"crossref","first-page":"5344","DOI":"10.1523\/JNEUROSCI.21-14-05344.2001","article-title":"Functional interaction between opioid and cannabinoid receptors in drug self-administration","volume":"21","author":"Navarro","year":"2001","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0750","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1523\/JNEUROSCI.12-07-02439.1992","article-title":"Molecular mechanisms of drug addiction","volume":"12","author":"Nestler","year":"1992","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0755","first-page":"23","article-title":"Cellular responses to chronic treatment with drugs of abuse","volume":"7","author":"Nestler","year":"1993","journal-title":"Crit Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0760","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am J Addict"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0765","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1126\/science.278.5335.58","article-title":"Molecular and cellular basis of addiction","volume":"278","author":"Nestler","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0770","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/0006-8993(89)91243-2","article-title":"Regulation of G proteins by chronic morphine in the rat locus coeruleus","volume":"476","author":"Nestler","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0775","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/0361-9230(94)90166-X","article-title":"Molecular and cellular mechanisms of opiate action: studies in the rat locus coeruleus","volume":"35","author":"Nestler","year":"1994","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0780","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/S0006-3223(99)00158-4","article-title":"Molecular control of locus coeruleus neurotransmission","volume":"46","author":"Nestler","year":"1999","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0785","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1037\/0893-164X.10.4.222","article-title":"Cannabis versus other illicit drug use among methadone maintenance patients","volume":"10","author":"Nirenberg","year":"1996","journal-title":"Psychol Addict Behav"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0790","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1046\/j.1360-0443.2003.00532.x","article-title":"Cannabis use and treatment outcome in methadone maintenance","volume":"98","author":"Nixon","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0795","doi-asserted-by":"crossref","first-page":"5487","DOI":"10.1073\/pnas.84.15.5487","article-title":"Mu and delta receptors belong to a family of receptors that are coupled to potassium channels","volume":"84","author":"North","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0800","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0010-440X(88)90060-0","article-title":"Nonnarcotic drug use over an addiction career \u2013 a study of heroin addicts in Baltimore and New York City","volume":"29","author":"Nurco","year":"1988","journal-title":"Compr Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0805","series-title":"Analyses of substance abuse and treatment need issues","author":"OAS","year":"1998"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0810","series-title":"National survey on drug use and health","article-title":"Results from the 2004 national survey on drug use and health: national findings","author":"OAS","year":"2005"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0815","series-title":"National survey on drug use and health","article-title":"Results from the 2008 national survey on drug use and health: national findings","author":"OAS","year":"2009"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0820","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S0074-7742(09)88012-4","article-title":"Cannabinoid receptors in brain: pharmacogenetics, neuropharmacology, neurotoxicology, and potential therapeutic applications","volume":"88","author":"Onaivi","year":"2009","journal-title":"Int Rev Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0825","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.brainres.2005.03.036","article-title":"Systemic administration of WIN 55,212-2 increases norepinephrine release in the rat frontal cortex","volume":"1046","author":"Oropeza","year":"2005","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0830","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2006.09.110","article-title":"Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex","volume":"1127","author":"Oropeza","year":"2007","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0835","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/0361-9230(94)90169-4","article-title":"Locus coeruleus activation by physiological challenges","volume":"35","author":"Page","year":"1994","journal-title":"Brain Res Bull"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0840","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pbb.2006.12.020","article-title":"Repeated cannabinoid administration increases indices of noradrenergic activity in rats","volume":"86","author":"Page","year":"2007","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0845","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.neulet.2007.11.009","article-title":"Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex","volume":"431","author":"Page","year":"2008","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0850","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2174\/138945010790980367","article-title":"Cellular mechanisms underlying the interaction between cannabinoid and opioid system","volume":"11","author":"Parolaro","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0855","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.jpainsymman.2005.01.011","article-title":"Molecular biology of opioid analgesia","volume":"29","author":"Pasternak","year":"2005","journal-title":"J Pain Symptom Manage"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0860","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/bmj.325.7374.1195","article-title":"Cannabis use and mental health in young people: cohort study","volume":"325","author":"Patton","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0865","doi-asserted-by":"crossref","first-page":"3729","DOI":"10.1073\/pnas.73.10.3729","article-title":"Opiate receptor: autoradiographic localization in rat brain","volume":"73","author":"Pert","year":"1976","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0870","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/(SICI)1098-2396(199908)33:2<141::AID-SYN4>3.0.CO;2-X","article-title":"Presence of mu-opioid receptors in targets of efferent projections from the central nucleus of the amygdala to the nucleus of the solitary tract","volume":"33","author":"Pickel","year":"1999","journal-title":"Synapse"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0875","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.neuroscience.2004.05.015","article-title":"Compartment-specific localization of cannabinoid 1 (CB1) and mu-opioid receptors in rat nucleus accumbens","volume":"127","author":"Pickel","year":"2004","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0880","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","article-title":"The molecular logic of endocannabinoid signalling","volume":"4","author":"Piomelli","year":"2003","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0885","first-page":"672","article-title":"The endocannabinoid system: a drug discovery perspective","volume":"6","author":"Piomelli","year":"2005","journal-title":"Curr Opin Investig Drugs"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0890","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1006\/nbdi.1998.0221","article-title":"Endogenous cannabinoid signaling","volume":"5","author":"Piomelli","year":"1998","journal-title":"Neurobiol Dis"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0895","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0006-8993(95)00560-D","article-title":"Antisense oligodeoxynucleotides to the kappa-1 receptor block the antinociceptive effects of delta 9-THC in the spinal cord","volume":"689","author":"Pugh","year":"1995","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0900","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3565(25)21168-5","article-title":"The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord","volume":"279","author":"Pugh","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0905","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S0022-3565(24)36640-6","article-title":"Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord","volume":"281","author":"Pugh","year":"1997","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0910","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/10550490902927785","article-title":"Intermittent marijuana use is associated with improved retention in naltrexone treatment for opiate-dependence","volume":"18","author":"Raby","year":"2009","journal-title":"Am J Addict"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0915","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","article-title":"Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation","volume":"25","author":"Ramirez","year":"2005","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0920","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/0006-8993(89)91466-2","article-title":"Withdrawal-induced activation of locus coeruleus neurons in opiate-dependent rats: attenuation by lesions of the nucleus paragigantocellularis","volume":"505","author":"Rasmussen","year":"1989","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0925","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1523\/JNEUROSCI.10-07-02308.1990","article-title":"Opiate withdrawal and the rat locus coeruleus: behavioral, electrophysiological, and biochemical correlates","volume":"10","author":"Rasmussen","year":"1990","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0930","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1111\/j.1526-4637.2009.00726.x","article-title":"The prevalence and significance of cannabis use in patients prescribed chronic opioid therapy: a review of the extant literature","volume":"10","author":"Reisfield","year":"2009","journal-title":"Pain Med"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0935","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.neulet.2006.11.069","article-title":"Ultrastructural evidence for co-localization of corticotropin-releasing factor receptor and mu-opioid receptor in the rat nucleus locus coeruleus","volume":"413","author":"Reyes","year":"2007","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0940","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/cne.21880","article-title":"Subcellular targeting of kappa-opioid receptors in the rat nucleus locus coeruleus","volume":"512","author":"Reyes","year":"2009","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0945","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.1002\/jnr.22158","article-title":"Cannabinoid modulation of cortical adrenergic receptors and transporters","volume":"87","author":"Reyes","year":"2009","journal-title":"J Neurosci Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1310","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.expneurol.2012.05.016","article-title":"Stress-induced sensitization of cortical adrenergic receptors following a history of cannabinoid exposure","volume":"236","author":"Reyes","year":"2012","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0955","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0163-7258(01)00160-7","article-title":"G-protein-coupled receptor dimerization: modulation of receptor function","volume":"92","author":"Rios","year":"2001","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0960","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/sj.bjp.0706757","article-title":"Mu opioid and CB1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis","volume":"148","author":"Rios","year":"2006","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0965","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ejphar.2005.11.036","article-title":"Synergistic affective analgesic interaction between delta-9-tetrahydrocannabinol and morphine","volume":"530","author":"Roberts","year":"2006","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0970","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2174\/138945010790980330","article-title":"Cannabinoids, opioids and MDMA: neuropsychological interactions related to addiction","volume":"11","author":"Robledo","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0975","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1192\/bjp.178.2.107","article-title":"Therapeutic aspects of cannabis and cannabinoids","volume":"178","author":"Robson","year":"2001","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0980","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1523\/JNEUROSCI.21-03-00823.2001","article-title":"Ultrastructural localization of the CB1 cannabinoid receptor in mu-opioid receptor patches of the rat Caudate putamen nucleus","volume":"21","author":"Rodriguez","year":"2001","journal-title":"J Neurosci"},{"issue":"1","key":"10.1016\/j.neuroscience.2013.04.034_b0985","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1600-0854.2010.01130.x","article-title":"Type I cannabinoid receptor trafficking: all roads lead to lysosome","volume":"12","author":"Rozenfeld","year":"2010","journal-title":"Traffic"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0990","doi-asserted-by":"crossref","first-page":"S108","DOI":"10.1016\/j.mce.2008.02.003","article-title":"Long lasting consequences of cannabis exposure in adolescence","volume":"286","author":"Rubino","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b0995","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1016\/S0024-3205(00)00547-6","article-title":"Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndrome","volume":"66","author":"Rubino","year":"2000","journal-title":"Life Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1000","doi-asserted-by":"crossref","first-page":"3689","DOI":"10.1097\/00001756-200112040-00017","article-title":"CB1-cannabinoid and mu-opioid receptor co-localization on postsynaptic target in the rat dorsal horn","volume":"12","author":"Salio","year":"2001","journal-title":"NeuroReport"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-328X(99)00255-7","article-title":"Effects of acute restraint stress on tyrosine hydroxylase mRNA expression in locus coeruleus of Wistar and Wistar-Kyoto rats","volume":"75","author":"Sands","year":"2000","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1010","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/nrn2573","article-title":"The locus coeruleus and noradrenergic modulation of cognition","volume":"10","author":"Sara","year":"2009","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1015","first-page":"306","article-title":"Marijuana use by methadone maintenance patients","volume":"105","author":"Saxon","year":"1990","journal-title":"NIDA Res Monogr"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1020","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1521-0391.1993.tb00421.x","article-title":"Urine screening for marijuana among methadone-maintained patients","volume":"2","author":"Saxon","year":"1993","journal-title":"Am J Addict"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1025","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ar.20860","article-title":"Mu-opioid receptor redistribution in the locus coeruleus upon precipitation of withdrawal in opiate-dependent rats","volume":"292","author":"Scavone","year":"2009","journal-title":"Anat Rec (Hoboken)"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1030","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.brainres.2009.11.023","article-title":"Characterization of cannabinoid-1 receptors in the locus coeruleus: relationship with mu-opioid receptors","volume":"1312","author":"Scavone","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1035","doi-asserted-by":"crossref","unstructured":"Scavone JL, Sterling R, Weinstein SP, Van Bockstaele E (2013) Impact of cannabis use during stabilization on methadone maintenance treatment. Am J Addict, in press, http:\/\/dx.doi.org\/10.1111\/j.1521-0391.2012.12044.x.","DOI":"10.1111\/j.1521-0391.2013.12044.x"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1040","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/j.neuropharm.2006.05.019","article-title":"Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core","volume":"51","author":"Schoffelmeer","year":"2006","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1045","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/s11064-009-0070-1","article-title":"Delayed increase of brain noradrenaline after acute footshock stress in rats","volume":"35","author":"Shinba","year":"2010","journal-title":"Neurochem Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1050","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1016\/j.neuropharm.2004.08.008","article-title":"Modulation of morphine-induced Fos-immunoreactivity by the cannabinoid receptor antagonist SR 141716","volume":"47","author":"Singh","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1055","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ejphar.2007.06.001","article-title":"Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors","volume":"571","author":"Smith","year":"2007","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1060","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/sj.npp.1300431","article-title":"Exposure to delta-9-tetrahydrocannabinol (THC) increases subsequent heroin taking but not heroin\u2019s reinforcing efficacy: a self-administration study in rats","volume":"29","author":"Solinas","year":"2004","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1065","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/nature03389","article-title":"Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice","volume":"434","author":"Steffens","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1070","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0079-6123(08)00433-0","article-title":"Role of the endocannabinoid system in regulation of the hypothalamic\u2013pituitary\u2013adrenocortical axis","volume":"170","author":"Steiner","year":"2008","journal-title":"Prog Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1075","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1016\/j.psyneuen.2008.06.004","article-title":"Conditional cannabinoid receptor type 1 mutants reveal neuron subpopulation-specific effects on behavioral and neuroendocrine stress responses","volume":"33","author":"Steiner","year":"2008","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1080","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1038\/42015","article-title":"A second endogenous cannabinoid that modulates long-term potentiation","volume":"388","author":"Stella","year":"1997","journal-title":"Nature"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1085","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/0006-8993(93)90055-R","article-title":"Autonomic areas of rat brain exhibit increased Fos-like immunoreactivity during opiate withdrawal in rats","volume":"624","author":"Stornetta","year":"1993","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1090","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1080\/105504999305749","article-title":"Lofexidine for opiate detoxification: review of recent randomised and open controlled trials","volume":"8","author":"Strang","year":"1999","journal-title":"Am J Addict"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1095","doi-asserted-by":"crossref","first-page":"556","DOI":"10.18553\/jmcp.2009.15.7.556","article-title":"Economic burden of prescription opioid misuse and abuse","volume":"15","author":"Strassels","year":"2009","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1100","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","article-title":"2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain","volume":"215","author":"Sugiura","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0014-2999(82)90314-4","article-title":"Brain catecholamine metabolites and behavior in morphine withdrawal","volume":"86","author":"Swann","year":"1982","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1110","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/3-540-26573-2_11","article-title":"Effects of cannabinoids on neurotransmission","author":"Szabo","year":"2005","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1115","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/BF02431544","article-title":"Clonidine infusions into the locus coeruleus attenuate behavioral and neurochemical changes associated with naloxone-precipitated withdrawal","volume":"96","author":"Taylor","year":"1988","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1120","doi-asserted-by":"crossref","first-page":"4308","DOI":"10.1073\/pnas.84.12.4308","article-title":"Neuroanatomical patterns of the mu, delta, and kappa opioid receptors of rat brain as determined by quantitative in vitro autoradiography","volume":"84","author":"Tempel","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1125","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.embor.7400052","article-title":"Roles of G-protein-coupled receptor dimerization","volume":"5","author":"Terrillon","year":"2004","journal-title":"EMBO Rep"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1130","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/sj.bjp.0706045","article-title":"Synergistic and additive interactions of the cannabinoid agonist CP55,940 with mu opioid receptor and alpha2-adrenoceptor agonists in acute pain models in mice","volume":"144","author":"Tham","year":"2005","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1135","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/138945010790980286","article-title":"Addiction and pain: cannabinoid and opioid interactions","volume":"11","author":"Tucci","year":"2010","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1315","unstructured":"Valentino, R.J., Aston-Jones, G (1995) Physiological and anatomical determinants of locus coeruleus discharge: behavioral and clinical implications. In: Bloom F, Kupfer D (editors), Psychopharmacology: Fourth Generation of Progress. Raven Press, New York; p. 373\u2013386."},{"key":"10.1016\/j.neuroscience.2013.04.034_b1145","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/0006-8993(83)90615-7","article-title":"Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus","volume":"270","author":"Valentino","year":"1983","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1150","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1749-6632.1993.tb49931.x","article-title":"The locus coeruleus as a site for integrating corticotropin-releasing factor and noradrenergic mediation of stress responses","volume":"697","author":"Valentino","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1155","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1054-3589(08)60863-7","article-title":"Activation of the locus ceruleus brain noradrenergic system during stress: circuitry, consequences, and regulation","volume":"42","author":"Valentino","year":"1998","journal-title":"Adv Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1160","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1046\/j.0953-816x.2001.01558.x","article-title":"Delta9-tetrahydrocannabinol releases and facilitates the effects of endogenous enkephalins: reduction in morphine withdrawal syndrome without change in rewarding effect","volume":"13","author":"Valverde","year":"2001","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1165","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/S0306-4522(01)00426-2","article-title":"Internalization of mu-opioid receptors produced by etorphine in the rat locus coeruleus","volume":"108","author":"Van Bockstaele","year":"2001","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1170","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1523\/JNEUROSCI.16-16-05037.1996","article-title":"Ultrastructural evidence for prominent distribution of the mu-opioid receptor at extrasynaptic sites on noradrenergic dendrites in the rat nucleus locus coeruleus","volume":"16","author":"Van Bockstaele","year":"1996","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1175","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/(SICI)1096-9861(19961202)376:1<65::AID-CNE4>3.0.CO;2-M","article-title":"Mu-opioid receptor is located on the plasma membrane of dendrites that receive asymmetric synapses from axon terminals containing leucine\u2013enkephalin in the rat nucleus locus coeruleus","volume":"376","author":"Van Bockstaele","year":"1996","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1180","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/(SICI)1096-9861(19971201)388:4<575::AID-CNE6>3.0.CO;2-#","article-title":"Delta-opioid receptor is present in presynaptic axon terminals in the rat nucleus locus coeruleus: relationships with methionine5-enkephalin","volume":"388","author":"Van Bockstaele","year":"1997","journal-title":"J Comp Neurol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1185","doi-asserted-by":"crossref","first-page":"8659","DOI":"10.1523\/JNEUROSCI.20-23-08659.2000","article-title":"Decreases in endogenous opioid peptides in the rat medullo-coerulear pathway after chronic morphine treatment","volume":"20","author":"Van Bockstaele","year":"2000","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1190","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1385\/MN:23:2-3:155","article-title":"Neuroadaptive responses in brainstem noradrenergic nuclei following chronic morphine exposure","volume":"23","author":"Van Bockstaele","year":"2001","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1195","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.pnpbp.2008.02.004","article-title":"Low dose naltrexone administration in morphine dependent rats attenuates withdrawal-induced norepinephrine efflux in forebrain","volume":"32","author":"Van Bockstaele","year":"2008","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1200","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.brainres.2009.09.036","article-title":"The locus coeruleus: a key nucleus where stress and opioids intersect to mediate vulnerability to opiate abuse","volume":"1314","author":"Van Bockstaele","year":"2010","journal-title":"Brain Res"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1205","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/0028-3908(95)00032-2","article-title":"Anandamide decreases naloxone-precipitated withdrawal signs in mice chronically treated with morphine","volume":"34","author":"Vela","year":"1995","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1210","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1111\/j.1460-9568.2004.03645.x","article-title":"Changes in endocannabinoid levels in a rat model of behavioural sensitization to morphine","volume":"20","author":"Vigano","year":"2004","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1215","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.pbb.2005.01.021","article-title":"Molecular and cellular basis of cannabinoid and opioid interactions","volume":"81","author":"Vigano","year":"2005","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1220","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00213-005-0114-4","article-title":"Molecular mechanisms involved in the asymmetric interaction between cannabinoid and opioid systems","volume":"182","author":"Vigano","year":"2005","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1225","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0376-8716(98)00092-1","article-title":"Factors associated with lapses to heroin use during methadone maintenance","volume":"52","author":"Wasserman","year":"1998","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1230","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1038\/sj.npp.1301263","article-title":"There and back again: a tale of norepinephrine and drug addiction","volume":"32","author":"Weinshenker","year":"2007","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1235","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/0740-5472(93)90075-D","article-title":"Long-term methadone maintenance treatment: some clinical examples","volume":"10","author":"Weinstein","year":"1993","journal-title":"J Subst Abuse Treat"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1240","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1046\/j.1440-1614.2003.01296.x","article-title":"Cannabis abuse is not a risk factor for treatment outcome in methadone maintenance treatment: a 1-year prospective study in an Israeli clinic","volume":"38","author":"Weizman","year":"2004","journal-title":"Aust N Z J Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1245","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1080\/09540260902782794","article-title":"Interaction of the cannabinoid and opioid systems in the modulation of nociception","volume":"21","author":"Welch","year":"2009","journal-title":"Int Rev Psychiatry"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1250","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0022-3565(25)10720-9","article-title":"Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice","volume":"262","author":"Welch","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1255","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/02791072.2003.10400007","article-title":"The clinical opiate withdrawal scale (COWS)","volume":"35","author":"Wesson","year":"2003","journal-title":"J Psychoactive Drugs"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1260","doi-asserted-by":"crossref","first-page":"10947","DOI":"10.1073\/pnas.91.23.10947","article-title":"Regulation of expression of cAMP response element-binding protein in the locus coeruleus in vivo and in a locus coeruleus-like cell line in vitro","volume":"91","author":"Widnell","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1265","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","article-title":"Endocannabinoid signaling in the brain","volume":"296","author":"Wilson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1270","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/00008877-200509000-00005","article-title":"A role for cannabinoid CB1 receptors in mood and anxiety disorders","volume":"16","author":"Witkin","year":"2005","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1275","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1073\/pnas.97.1.325","article-title":"Pronounced and sustained central hypernoradrenergic function in major depression with melancholic features: relation to hypercortisolism and corticotropin-releasing hormone","volume":"97","author":"Wong","year":"2000","journal-title":"Proc Nat Acad Sci U S A"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1280","doi-asserted-by":"crossref","first-page":"8193","DOI":"10.1523\/JNEUROSCI.1657-04.2004","article-title":"Chronic morphine sensitizes the brain norepinephrine system to corticotropin-releasing factor and stress","volume":"24","author":"Xu","year":"2004","journal-title":"J Neurosci"},{"key":"10.1016\/j.neuroscience.2013.04.034_b1285","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0006-8993(01)02655-5","article-title":"Endogenous cannabinoid, 2-arachidonoylglycerol, attenuates naloxone-precipitated withdrawal signs in morphine-dependent mice","volume":"909","author":"Yamaguchi","year":"2001","journal-title":"Brain Res"}],"container-title":["Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221300359X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S030645221300359X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T02:25:35Z","timestamp":1745979935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S030645221300359X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,9]]},"references-count":257,"alternative-id":["S030645221300359X"],"URL":"https:\/\/doi.org\/10.1016\/j.neuroscience.2013.04.034","relation":{},"ISSN":["0306-4522"],"issn-type":[{"value":"0306-4522","type":"print"}],"subject":[],"published":{"date-parts":[[2013,9]]}}}